Literature DB >> 627534

Effects of streptomycin and novobiocin on Staphylococcus aureus gene expression.

K Nordström, M Lindberg.   

Abstract

Streptomycin and novobiocin induced production of protein A and inhibited production of alpha- and beta-hemolysins in mutants of Staphylococcus aureus strains RN450 and RN1 resistant to these antibiotics. Streptomycin, but not novobiocin, also inhibited propagation of bacteriophages of serological group B, whereas phages of group A were unaffected. Streptomycin had to be present at adsorption of the phage, and 10 mM CACL2 reversed the inhibitory effect. Lysogenization and competence induction occurred in the presence of streptomycin, suggesting that some early phage genes were expressed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627534      PMCID: PMC222066          DOI: 10.1128/jb.133.2.614-620.1978

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  26 in total

1.  ANALYSIS BY TRANSDUCTION OF MUTATIONS AFFECTING PENICILLINASE FORMATION IN STAPHYLOCOCCUS AUREUS.

Authors:  R P NOVICK
Journal:  J Gen Microbiol       Date:  1963-10

2.  THE SYNTHESIS OF TEICHOIC ACIDS. II. POLYRIBITOL PHOSPHATE.

Authors:  L GLASER
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

3.  SEROLOGY, DENSITY, AND MORPHOLOGY OF STAPHYLOCOCCAL PHAGES.

Authors:  E D ROSENBLUM; S TYRONE
Journal:  J Bacteriol       Date:  1964-12       Impact factor: 3.490

4.  The effect of antibiotics on the toxin production of Staphylococcus aureus.

Authors:  N A HINTON; J H ORR
Journal:  Antibiot Chemother (Northfield)       Date:  1960-12

5.  Effect of novobiocin on permeability of Escherichia coli.

Authors:  T D BROCK; M L BROCK
Journal:  Arch Biochem Biophys       Date:  1959-11       Impact factor: 4.013

6.  Formation of extracellular protein A by Staphylococcus aureus.

Authors:  J Movitz
Journal:  Eur J Biochem       Date:  1976-09

7.  Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.

Authors:  M Gellert; M H O'Dea; T Itoh; J Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

8.  BIOCHEMICAL EFFECTS OF NOVOBIOCIN ON STAPHYLOCOCCUS AUREUS.

Authors:  R M WISHNOW; J L STROMINGER; C H BIRGE; R H THRENN
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

9.  STREPTOMYCIN AS AN ANTIVIRAL AGENT: MODE OF ACTION.

Authors:  T D BROCK; S O WOOLEY
Journal:  Science       Date:  1963-09-13       Impact factor: 47.728

10.  The characterization of staphylococcal toxins. I. The electrophoretic migration of the alpha hemolytic, dermonecrotic, lethal, and leucocidal activities of crude toxin.

Authors:  S KUMAR; R K LINDORFER
Journal:  J Exp Med       Date:  1962-06-01       Impact factor: 14.307

View more
  5 in total

1.  Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis.

Authors:  R Vasishta; M Saxena; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

2.  Differential inhibition of bacterial growth and hemolysin production by lincosamide antibiotics.

Authors:  A M Shibl; I A Al-Sowaygh
Journal:  J Bacteriol       Date:  1979-02       Impact factor: 3.490

3.  Expression of the gene encoding protein A in Staphylococcus aureus and coagulase-negative staphylococci.

Authors:  M Uhlén; B Guss; B Nilsson; F Götz; M Lindberg
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

4.  Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement.

Authors:  A H Patel; P Nowlan; E D Weavers; T Foster
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Efficient secretion and purification of human insulin-like growth factor I with a gene fusion vector in Staphylococci.

Authors:  B Nilsson; E Holmgren; S Josephson; S Gatenbeck; L Philipson; M Uhlen
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.